XML 63 R47.htm IDEA: XBRL DOCUMENT v3.25.3
Note 16 - Income Taxes (Tables)
12 Months Ended
Sep. 30, 2025
Notes Tables  
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
  

Year Ended September 30,

 
  

2025

  

2024

  

2023

 

Current income tax expense (benefit)

            

Federal

 $(45,468) $227  $(45)

State

  1,439   1,602   1,672 

Foreign

  12,265   11,150   8,549 

Total current income tax expense

  (31,764)  12,979   10,176 

Deferred income tax expense (benefit):

            

Federal

  291   (4,773)  (18,737)

State

  59   1,318   (390)

Foreign

  (187)  (4,283)  (3,014)

Total deferred income tax expense (benefit)

  163   (7,738)  (22,141)

Income tax expense (benefit)

 $(31,601) $5,241  $(11,965)
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
  

Year Ended September 30,

 
  

2025

  

2024

  

2023

 

Domestic

 $(33,676) $(39,648) $(53,400)

Foreign

  26,533   20,523   33,395 

Loss from continuing operations before income taxes

 $(7,143) $(19,125) $(20,005)
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
  

Year Ended September 30,

 
  

2025

  

2024

  

2023

 

Income tax benefit computed at federal statutory rate

 $(1,500) $(3,945) $(4,129)

State income taxes, net of federal benefit

  (593)  (598)  (696)

Foreign income taxed at different rates

  953   (3,521)  1,477 

Worthless stock deduction

  (45,600)      

Impact of investments in subsidiaries

  (23,348)  (22,583)  (6,059)

Change in deferred tax asset valuation allowance

  36,475   31,793   (7)

Impact of change in uncertain tax positions

  (398)  36   (1,321)

Global intangible low taxed income, net of foreign tax credits

  4,914   3,767   310 

Impact of tax rate changes

  (928)  (46)  (1,391)

Compensation

  1,353   1,413   1,484 

Tax credits

  (1,538)  (1,199)  (1,425)

Other non-deductible expenses and other taxes

  (111)  1,461   1,069 

Research and development expense deduction

  (1,280)  (1,337)  (1,277)

Income tax (benefit) expense

 $(31,601) $5,241  $(11,965)
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
  

September 30,

 
  

2025

  

2024

 

Accruals and reserves not currently deductible

 $9,137  $10,291 

Federal, state and foreign tax credits

  2,326   1,151 

Other assets

  2,894   1,213 

Equity compensation

  3,776   2,359 

Loss carryforwards

  86,724   44,356 

Lease liabilities

  14,789   16,283 

Capitalized research and development

  7,035   6,253 

Deferred revenue

  2,954   3,573 

Net unrealized loss on hedging and investments

  8,241   527 

Deferred tax assets

  137,876   86,006 

Depreciation and intangible amortization

  (37,019)  (43,756)

Right-of-use assets

  (13,626)  (15,217)

Other liabilities

  (904)  (605)

Outside basis differences in subsidiaries

  (2,149)   

Deferred tax liabilities

  (53,698)  (59,578)

Valuation allowance

  (102,021)  (44,222)

Net deferred tax liability

 $(17,843) $(17,794)
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]
  

Year Ended September 30,

 
  

2025

  

2024

  

2023

 
             

Balance at beginning of period

 $298  $1,679  $2,006 

Additions from current year positions

  2,500       

Reductions from lapses in statutes of limitation

  (298)  (1,381)  (327)

Balance at end of period

 $2,500  $298  $1,679